Tenn. Comp. R. & Regs. 0940-05-35-.14

Current through June 10, 2024
Section 0940-05-35-.14 - DRUG SCREENS
(1) Random observed urine drug screening and other adequately tested toxicological procedures shall be used for the purposes of assessing the patient's abuse of drugs and evaluating a patient's progress in treatment.
(2) Drug screening procedures shall be individualized and shall follow the required drug screen frequency described in 0940-05-35-.09.
(3) More frequent collection and analysis of drug samples during episodes of relapse or medically-supervised or other types of withdrawal may occur.
(4) Collection and testing shall be done in a manner that assures that samples collected from patients is unadulterated. Such collection and testing shall include random direct observation that is conducted professionally, ethically, and in a manner which respects service recipients' privacy.
(5) A positive test is a test that results in the presence of any drug or substances that is illegal or for which the patient cannot provide a valid prescription or any drug or substance prohibited by the Facility. Any refusal to participate in a random drug test assigned by the Facility shall also be considered a positive result.
(6) The Facility shall document both the results of toxicological tests and the follow-up therapeutic action taken in the patient record.
(7) Absence of medications prescribed by the Facility for the service recipient shall be considered evidence of possible medication diversion and evaluated by the program physician accordingly.
(8) Nothing contained in this rule shall preclude any Facility from administering any additional drug tests it determines necessary.

Tenn. Comp. R. & Regs. 0940-05-35-.14

Original rules filed October 14, 2016; effective January 12, 2017. Rule was previously numbered 0940-05-35-.13 but was renumbered 0940-05-35-.14 with the introduction of a new rule 0940-05-35-.10 filed March 29, 2019; effective 6/27/2019.

Authority: T.C.A. §§ 4-3-1601, 4-1-103, 33-1-302, 33-1-305, 33-1-309, 33-2-301, 33-2-302, 33-2-402, 33-2-403, 33-2-404, 33-2-407, and Chapter 912 of the Public Acts of 2016.